CliffBio
small molecule

CLEMASTINE FUMARATE

CLEMASTINE FUMARATE

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLEMASTINE FUMARATE
Active ingredientCLEMASTINE FUMARATE
Strength2.68MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 1992
Marketing statusRX

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CLEMASTINE FUMARATE patent cliff — loss of exclusivity — | CliffBio